Cancer Management & Treatment | Cancer Research & Drug Trials

Top News

Second-Generation Antiandrogens Linked to Falls, Cognitive Toxicity in Prostate Cancer Patients

Olvimulogene Nanivacirepvec May Reverse Platinum Resistance, Refractoriness in Ovarian Cancer

Genomic Profiling in Cancer of Unknown Primary Feasible but Challenging

Anti-PD-L1 Combinations Produce Mixed Results in Metastatic RCC

Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery

COVID-19 Pandemic Created Challenges for Interpreting Trends in Cancer Incidence

Medicaid Expansion Tied to Decrease in Distant Stage Cancer Diagnoses and Deaths

Neuroblastoma Survivors Report Neurocognitive Impairment, Failure to Reach Milestones

Real-World mCSPC First-Line Treatment Intensification Remains Low

More Older Americans Use Online Patient Portals

FDA Grants Full Approval to Paxlovid for Treatment of COVID-19

Brain Tumors Are Major Contributor to US Cancer Burden

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.
Global Survey Suggests RCC Patients Are Underinformed, Face Obstacles to Care

Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Lack of Access to Abortion Has Had a Negative Impact on Cancer Care

Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients

The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
AATS 2023

News from the American Association for Thoracic Surgery Annual Meeting

More Features

Lung cancer

AACR 2023 Highlights Novel Research in NSCLC and ES-SCLC

By

Tori Rodriguez, MA, LPC, AHC

Could Shopping Data Be Used to Predict Cancer and Diagnose It Earlier?

By

Carina Storrs, PhD

Could mRNA Vaccines Help Prevent Recurrence in Pancreatic Cancer?

By

Alan P. Lyss, MD

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

Cancer patient receiving chemotherapy

Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers

By

Joyce Pagan

More Features »

Fact Sheets

Vaccination

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

COVID-19 testing

What to Expect: Enrolling on a Cancer Clinical Trial During COVID-19